Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significan...
read more